nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Convulsion—Docetaxel—lung cancer	0.00026	0.000412	CcSEcCtD
Acamprosate—Paraesthesia—Paclitaxel—lung cancer	0.00026	0.000411	CcSEcCtD
Acamprosate—Hypertension—Docetaxel—lung cancer	0.000259	0.000411	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—lung cancer	0.000259	0.00041	CcSEcCtD
Acamprosate—Dyspnoea—Paclitaxel—lung cancer	0.000258	0.000408	CcSEcCtD
Acamprosate—Somnolence—Paclitaxel—lung cancer	0.000257	0.000407	CcSEcCtD
Acamprosate—Decreased appetite—Etoposide—lung cancer	0.000256	0.000406	CcSEcCtD
Acamprosate—Arthralgia—Docetaxel—lung cancer	0.000256	0.000405	CcSEcCtD
Acamprosate—Chest pain—Docetaxel—lung cancer	0.000256	0.000405	CcSEcCtD
Acamprosate—Myalgia—Docetaxel—lung cancer	0.000256	0.000405	CcSEcCtD
Acamprosate—Nausea—Vinorelbine—lung cancer	0.000255	0.000404	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Etoposide—lung cancer	0.000255	0.000403	CcSEcCtD
Acamprosate—Dyspepsia—Paclitaxel—lung cancer	0.000255	0.000403	CcSEcCtD
Acamprosate—Body temperature increased—Cisplatin—lung cancer	0.000254	0.000403	CcSEcCtD
Acamprosate—Asthenia—Irinotecan—lung cancer	0.000254	0.000403	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000254	0.000402	CcSEcCtD
Acamprosate—Pain—Etoposide—lung cancer	0.000252	0.000399	CcSEcCtD
Acamprosate—Constipation—Etoposide—lung cancer	0.000252	0.000399	CcSEcCtD
Acamprosate—Decreased appetite—Paclitaxel—lung cancer	0.000251	0.000398	CcSEcCtD
Acamprosate—Dry mouth—Docetaxel—lung cancer	0.00025	0.000396	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—lung cancer	0.00025	0.000396	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00025	0.000395	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—lung cancer	0.000249	0.000394	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—lung cancer	0.000249	0.000394	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—lung cancer	0.000248	0.000394	CcSEcCtD
Acamprosate—Asthenia—Gemcitabine—lung cancer	0.000248	0.000392	CcSEcCtD
Acamprosate—Constipation—Paclitaxel—lung cancer	0.000247	0.000392	CcSEcCtD
Acamprosate—Pain—Paclitaxel—lung cancer	0.000247	0.000392	CcSEcCtD
Acamprosate—Confusional state—Docetaxel—lung cancer	0.000247	0.000391	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—lung cancer	0.000247	0.000391	CcSEcCtD
Acamprosate—Photosensitivity reaction—Doxorubicin—lung cancer	0.000246	0.000389	CcSEcCtD
Acamprosate—Anaphylactic shock—Docetaxel—lung cancer	0.000245	0.000388	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—lung cancer	0.000245	0.000388	CcSEcCtD
Acamprosate—Pruritus—Gemcitabine—lung cancer	0.000244	0.000387	CcSEcCtD
Acamprosate—Infection—Docetaxel—lung cancer	0.000243	0.000386	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—lung cancer	0.000243	0.000385	CcSEcCtD
Acamprosate—Feeling abnormal—Etoposide—lung cancer	0.000243	0.000385	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—lung cancer	0.000243	0.000384	CcSEcCtD
Acamprosate—Diarrhoea—Irinotecan—lung cancer	0.000243	0.000384	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—lung cancer	0.000241	0.000382	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—lung cancer	0.000241	0.000382	CcSEcCtD
Acamprosate—Shock—Docetaxel—lung cancer	0.000241	0.000382	CcSEcCtD
Acamprosate—Thrombocytopenia—Docetaxel—lung cancer	0.00024	0.00038	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—lung cancer	0.00024	0.00038	CcSEcCtD
Acamprosate—Tachycardia—Docetaxel—lung cancer	0.000239	0.000379	CcSEcCtD
Acamprosate—Feeling abnormal—Paclitaxel—lung cancer	0.000238	0.000377	CcSEcCtD
Acamprosate—Skin disorder—Docetaxel—lung cancer	0.000238	0.000377	CcSEcCtD
Acamprosate—Hypersensitivity—Cisplatin—lung cancer	0.000237	0.000376	CcSEcCtD
Acamprosate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000236	0.000375	CcSEcCtD
Acamprosate—Diarrhoea—Gemcitabine—lung cancer	0.000236	0.000374	CcSEcCtD
Acamprosate—Dizziness—Irinotecan—lung cancer	0.000234	0.000371	CcSEcCtD
Acamprosate—Urticaria—Etoposide—lung cancer	0.000234	0.000371	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—lung cancer	0.000234	0.00037	CcSEcCtD
Acamprosate—Anorexia—Docetaxel—lung cancer	0.000234	0.00037	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—lung cancer	0.000233	0.000369	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—lung cancer	0.000233	0.000369	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—lung cancer	0.000233	0.000369	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—lung cancer	0.000232	0.000367	CcSEcCtD
Acamprosate—Asthenia—Cisplatin—lung cancer	0.000231	0.000366	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—lung cancer	0.00023	0.000364	CcSEcCtD
Acamprosate—Urticaria—Paclitaxel—lung cancer	0.00023	0.000364	CcSEcCtD
Acamprosate—Hypotension—Docetaxel—lung cancer	0.000229	0.000363	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—lung cancer	0.000229	0.000362	CcSEcCtD
Acamprosate—Body temperature increased—Paclitaxel—lung cancer	0.000229	0.000362	CcSEcCtD
Acamprosate—Abdominal pain—Paclitaxel—lung cancer	0.000229	0.000362	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—lung cancer	0.000226	0.000358	CcSEcCtD
Acamprosate—Vomiting—Irinotecan—lung cancer	0.000225	0.000357	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—lung cancer	0.000225	0.000356	CcSEcCtD
Acamprosate—Rash—Irinotecan—lung cancer	0.000224	0.000354	CcSEcCtD
Acamprosate—Dermatitis—Irinotecan—lung cancer	0.000223	0.000354	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000223	0.000354	CcSEcCtD
Acamprosate—Chills—Methotrexate—lung cancer	0.000223	0.000353	CcSEcCtD
Acamprosate—Headache—Irinotecan—lung cancer	0.000222	0.000352	CcSEcCtD
Acamprosate—Insomnia—Docetaxel—lung cancer	0.000222	0.000351	CcSEcCtD
Acamprosate—Diarrhoea—Cisplatin—lung cancer	0.00022	0.000349	CcSEcCtD
Acamprosate—Paraesthesia—Docetaxel—lung cancer	0.00022	0.000349	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—lung cancer	0.00022	0.000348	CcSEcCtD
Acamprosate—Vomiting—Gemcitabine—lung cancer	0.00022	0.000348	CcSEcCtD
Acamprosate—Dyspnoea—Docetaxel—lung cancer	0.000219	0.000346	CcSEcCtD
Acamprosate—Somnolence—Docetaxel—lung cancer	0.000218	0.000345	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—lung cancer	0.000218	0.000345	CcSEcCtD
Acamprosate—Rash—Gemcitabine—lung cancer	0.000218	0.000345	CcSEcCtD
Acamprosate—Dermatitis—Gemcitabine—lung cancer	0.000218	0.000345	CcSEcCtD
Acamprosate—Hypersensitivity—Etoposide—lung cancer	0.000217	0.000344	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—lung cancer	0.000216	0.000343	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—lung cancer	0.000216	0.000343	CcSEcCtD
Acamprosate—Headache—Gemcitabine—lung cancer	0.000216	0.000343	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—lung cancer	0.000216	0.000342	CcSEcCtD
Acamprosate—Dyspepsia—Docetaxel—lung cancer	0.000216	0.000342	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—lung cancer	0.000215	0.000341	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—lung cancer	0.000215	0.000341	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—lung cancer	0.000214	0.000339	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—lung cancer	0.000214	0.000338	CcSEcCtD
Acamprosate—Decreased appetite—Docetaxel—lung cancer	0.000213	0.000337	CcSEcCtD
Acamprosate—Hypersensitivity—Paclitaxel—lung cancer	0.000213	0.000337	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—lung cancer	0.000212	0.000336	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—lung cancer	0.000212	0.000336	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Docetaxel—lung cancer	0.000212	0.000335	CcSEcCtD
Acamprosate—Asthenia—Etoposide—lung cancer	0.000212	0.000335	CcSEcCtD
Acamprosate—Nausea—Irinotecan—lung cancer	0.000211	0.000334	CcSEcCtD
Acamprosate—Pain—Docetaxel—lung cancer	0.00021	0.000332	CcSEcCtD
Acamprosate—Constipation—Docetaxel—lung cancer	0.00021	0.000332	CcSEcCtD
Acamprosate—Back pain—Methotrexate—lung cancer	0.000209	0.000332	CcSEcCtD
Acamprosate—Pruritus—Etoposide—lung cancer	0.000209	0.00033	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—lung cancer	0.000207	0.000329	CcSEcCtD
Acamprosate—Asthenia—Paclitaxel—lung cancer	0.000207	0.000329	CcSEcCtD
Acamprosate—Nausea—Gemcitabine—lung cancer	0.000205	0.000325	CcSEcCtD
Acamprosate—Vomiting—Cisplatin—lung cancer	0.000205	0.000324	CcSEcCtD
Acamprosate—Pruritus—Paclitaxel—lung cancer	0.000205	0.000324	CcSEcCtD
Acamprosate—Rash—Cisplatin—lung cancer	0.000203	0.000321	CcSEcCtD
Acamprosate—Dermatitis—Cisplatin—lung cancer	0.000203	0.000321	CcSEcCtD
Acamprosate—Feeling abnormal—Docetaxel—lung cancer	0.000202	0.00032	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—lung cancer	0.000202	0.00032	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—lung cancer	0.000201	0.000318	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—lung cancer	0.000201	0.000318	CcSEcCtD
Acamprosate—Gastrointestinal pain—Docetaxel—lung cancer	0.0002	0.000317	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—lung cancer	0.0002	0.000317	CcSEcCtD
Acamprosate—Diarrhoea—Paclitaxel—lung cancer	0.000198	0.000313	CcSEcCtD
Acamprosate—Malaise—Methotrexate—lung cancer	0.000195	0.000309	CcSEcCtD
Acamprosate—Dizziness—Etoposide—lung cancer	0.000195	0.000309	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—lung cancer	0.000194	0.000308	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—lung cancer	0.000194	0.000308	CcSEcCtD
Acamprosate—Abdominal pain—Docetaxel—lung cancer	0.000194	0.000307	CcSEcCtD
Acamprosate—Body temperature increased—Docetaxel—lung cancer	0.000194	0.000307	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—lung cancer	0.000194	0.000307	CcSEcCtD
Acamprosate—Chills—Doxorubicin—lung cancer	0.000193	0.000306	CcSEcCtD
Acamprosate—Dizziness—Paclitaxel—lung cancer	0.000191	0.000303	CcSEcCtD
Acamprosate—Nausea—Cisplatin—lung cancer	0.000191	0.000303	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—lung cancer	0.00019	0.000301	CcSEcCtD
Acamprosate—Cough—Methotrexate—lung cancer	0.000189	0.000299	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—lung cancer	0.000189	0.000299	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—lung cancer	0.000188	0.000297	CcSEcCtD
Acamprosate—Vomiting—Etoposide—lung cancer	0.000188	0.000297	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—lung cancer	0.000187	0.000297	CcSEcCtD
Acamprosate—Rash—Etoposide—lung cancer	0.000186	0.000295	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—lung cancer	0.000186	0.000294	CcSEcCtD
Acamprosate—Headache—Etoposide—lung cancer	0.000185	0.000293	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—lung cancer	0.000185	0.000293	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—lung cancer	0.000184	0.000292	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—lung cancer	0.000184	0.000292	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—lung cancer	0.000184	0.000292	CcSEcCtD
Acamprosate—Tension—Doxorubicin—lung cancer	0.000184	0.000291	CcSEcCtD
Acamprosate—Vomiting—Paclitaxel—lung cancer	0.000184	0.000291	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—lung cancer	0.000184	0.000291	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000183	0.00029	CcSEcCtD
Acamprosate—Rash—Paclitaxel—lung cancer	0.000182	0.000289	CcSEcCtD
Acamprosate—Dermatitis—Paclitaxel—lung cancer	0.000182	0.000289	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—lung cancer	0.000182	0.000288	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—lung cancer	0.000182	0.000288	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—lung cancer	0.000181	0.000287	CcSEcCtD
Acamprosate—Headache—Paclitaxel—lung cancer	0.000181	0.000287	CcSEcCtD
Acamprosate—Hypersensitivity—Docetaxel—lung cancer	0.000181	0.000286	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—lung cancer	0.00018	0.000285	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—lung cancer	0.000178	0.000282	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—lung cancer	0.000177	0.00028	CcSEcCtD
Acamprosate—Asthenia—Docetaxel—lung cancer	0.000176	0.000279	CcSEcCtD
Acamprosate—Infection—Methotrexate—lung cancer	0.000175	0.000278	CcSEcCtD
Acamprosate—Nausea—Etoposide—lung cancer	0.000175	0.000277	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—lung cancer	0.000174	0.000275	CcSEcCtD
Acamprosate—Pruritus—Docetaxel—lung cancer	0.000173	0.000275	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—lung cancer	0.000173	0.000274	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—lung cancer	0.000173	0.000274	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—lung cancer	0.000172	0.000273	CcSEcCtD
Acamprosate—Nausea—Paclitaxel—lung cancer	0.000172	0.000272	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—lung cancer	0.000172	0.000272	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—lung cancer	0.000171	0.00027	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—lung cancer	0.000169	0.000268	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—lung cancer	0.000168	0.000267	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—lung cancer	0.000168	0.000267	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—lung cancer	0.000168	0.000266	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—lung cancer	0.000168	0.000266	CcSEcCtD
Acamprosate—Diarrhoea—Docetaxel—lung cancer	0.000168	0.000266	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—lung cancer	0.000166	0.000262	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—lung cancer	0.000165	0.000261	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—lung cancer	0.000165	0.000261	CcSEcCtD
Acamprosate—Cough—Doxorubicin—lung cancer	0.000164	0.000259	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—lung cancer	0.000162	0.000257	CcSEcCtD
Acamprosate—Dizziness—Docetaxel—lung cancer	0.000162	0.000257	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—lung cancer	0.000162	0.000256	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000161	0.000255	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—lung cancer	0.00016	0.000253	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—lung cancer	0.00016	0.000253	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—lung cancer	0.00016	0.000253	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—lung cancer	0.00016	0.000253	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—lung cancer	0.000159	0.000252	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—lung cancer	0.000159	0.000251	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000158	0.000251	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—lung cancer	0.000158	0.00025	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—lung cancer	0.000157	0.000249	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—lung cancer	0.000157	0.000249	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—lung cancer	0.000156	0.000247	CcSEcCtD
Acamprosate—Vomiting—Docetaxel—lung cancer	0.000156	0.000247	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—lung cancer	0.000155	0.000246	CcSEcCtD
Acamprosate—Rash—Docetaxel—lung cancer	0.000155	0.000245	CcSEcCtD
Acamprosate—Dermatitis—Docetaxel—lung cancer	0.000154	0.000245	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—lung cancer	0.000154	0.000244	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—lung cancer	0.000154	0.000243	CcSEcCtD
Acamprosate—Headache—Docetaxel—lung cancer	0.000154	0.000243	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—lung cancer	0.000153	0.000242	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000153	0.000242	CcSEcCtD
Acamprosate—Infection—Doxorubicin—lung cancer	0.000152	0.000241	CcSEcCtD
Acamprosate—Pain—Methotrexate—lung cancer	0.000151	0.000239	CcSEcCtD
Acamprosate—Shock—Doxorubicin—lung cancer	0.00015	0.000238	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—lung cancer	0.00015	0.000237	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—lung cancer	0.000149	0.000236	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—lung cancer	0.000149	0.000235	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—lung cancer	0.000148	0.000234	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—lung cancer	0.000146	0.000231	CcSEcCtD
Acamprosate—Nausea—Docetaxel—lung cancer	0.000146	0.000231	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—lung cancer	0.000146	0.000231	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—RAF1—lung cancer	0.000145	0.000395	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—lung cancer	0.000145	0.000394	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000145	0.000394	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Methotrexate—lung cancer	0.000144	0.000229	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—lung cancer	0.000143	0.000226	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—JUNB—lung cancer	0.000143	0.000387	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000143	0.000387	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000142	0.000386	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—lung cancer	0.000142	0.000385	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HES1—lung cancer	0.000142	0.000385	CbGpPWpGaD
Acamprosate—Urticaria—Methotrexate—lung cancer	0.00014	0.000222	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—lung cancer	0.00014	0.00038	CbGpPWpGaD
Acamprosate—Body temperature increased—Methotrexate—lung cancer	0.00014	0.000221	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—lung cancer	0.00014	0.000221	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000139	0.000221	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000139	0.000376	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—lung cancer	0.000139	0.000376	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HES1—lung cancer	0.000138	0.000375	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000138	0.000375	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—lung cancer	0.000138	0.000219	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000137	0.000373	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—lung cancer	0.000137	0.000373	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—lung cancer	0.000137	0.000218	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—lung cancer	0.000136	0.000216	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—IL6R—lung cancer	0.000136	0.00037	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—lung cancer	0.000136	0.00037	CbGpPWpGaD
Acamprosate—Somnolence—Doxorubicin—lung cancer	0.000136	0.000215	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—lung cancer	0.000135	0.000213	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—lung cancer	0.000134	0.000364	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BRAF—lung cancer	0.000134	0.000363	CbGpPWpGaD
Acamprosate—Decreased appetite—Doxorubicin—lung cancer	0.000133	0.000211	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—IL6R—lung cancer	0.000133	0.000361	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—RAF1—lung cancer	0.000132	0.000359	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000132	0.000209	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—POMC—lung cancer	0.000132	0.000358	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000132	0.000357	CbGpPWpGaD
Acamprosate—Constipation—Doxorubicin—lung cancer	0.000131	0.000207	CcSEcCtD
Acamprosate—Pain—Doxorubicin—lung cancer	0.000131	0.000207	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—lung cancer	0.000131	0.000354	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.00013	0.000354	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.00013	0.000354	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MDM2—lung cancer	0.00013	0.000354	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—lung cancer	0.00013	0.000354	CbGpPWpGaD
Acamprosate—Hypersensitivity—Methotrexate—lung cancer	0.00013	0.000206	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MMP2—lung cancer	0.00013	0.000353	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—RAF1—lung cancer	0.00013	0.000353	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAP2K1—lung cancer	0.00013	0.000352	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—RAF1—lung cancer	0.00013	0.000352	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STK11—lung cancer	0.00013	0.000352	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6R—lung cancer	0.000129	0.000349	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000128	0.000348	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000128	0.000348	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000128	0.000348	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000128	0.000346	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MDM2—lung cancer	0.000127	0.000345	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—lung cancer	0.000127	0.000344	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—lung cancer	0.000127	0.000344	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—lung cancer	0.000127	0.000201	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MAP2K1—lung cancer	0.000127	0.000344	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—RAF1—lung cancer	0.000127	0.000343	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—lung cancer	0.000126	0.0002	CcSEcCtD
Acamprosate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000125	0.000198	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FOXO3—lung cancer	0.000125	0.000339	CbGpPWpGaD
Acamprosate—Pruritus—Methotrexate—lung cancer	0.000125	0.000198	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000125	0.000338	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000124	0.000337	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000124	0.000337	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAP2K1—lung cancer	0.000123	0.000332	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—lung cancer	0.000122	0.00033	CbGpPWpGaD
Acamprosate—Urticaria—Doxorubicin—lung cancer	0.000122	0.000192	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—lung cancer	0.000121	0.000329	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TF—lung cancer	0.000121	0.000329	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000121	0.000328	CbGpPWpGaD
Acamprosate—Abdominal pain—Doxorubicin—lung cancer	0.000121	0.000192	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—lung cancer	0.000121	0.000192	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—lung cancer	0.000121	0.000191	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—FGFR1—lung cancer	0.000121	0.000328	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TF—lung cancer	0.000119	0.000323	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—lung cancer	0.000118	0.000321	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGFR1—lung cancer	0.000118	0.000319	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AVP—lung cancer	0.000117	0.000318	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—lung cancer	0.000117	0.000317	CbGpPWpGaD
Acamprosate—Dizziness—Methotrexate—lung cancer	0.000117	0.000185	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—RAF1—lung cancer	0.000115	0.000313	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000115	0.000312	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ERBB2—lung cancer	0.000114	0.000309	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—lung cancer	0.000114	0.000309	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—lung cancer	0.000114	0.000309	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—RAF1—lung cancer	0.000114	0.000308	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—lung cancer	0.000113	0.000306	CbGpPWpGaD
Acamprosate—Hypersensitivity—Doxorubicin—lung cancer	0.000113	0.000179	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—RAF1—lung cancer	0.000112	0.000305	CbGpPWpGaD
Acamprosate—Vomiting—Methotrexate—lung cancer	0.000112	0.000178	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—lung cancer	0.000112	0.000305	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000112	0.000304	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000112	0.000304	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000112	0.000304	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—RAF1—lung cancer	0.000112	0.000303	CbGpPWpGaD
Acamprosate—Rash—Methotrexate—lung cancer	0.000111	0.000176	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MET—lung cancer	0.000111	0.000302	CbGpPWpGaD
Acamprosate—Dermatitis—Methotrexate—lung cancer	0.000111	0.000176	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—ERBB2—lung cancer	0.000111	0.000302	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—lung cancer	0.000111	0.000301	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HES1—lung cancer	0.000111	0.000301	CbGpPWpGaD
Acamprosate—Headache—Methotrexate—lung cancer	0.000111	0.000175	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MDM2—lung cancer	0.00011	0.000299	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.00011	0.000298	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—RAF1—lung cancer	0.00011	0.000298	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—lung cancer	0.00011	0.000298	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—lung cancer	0.00011	0.000174	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000109	0.000296	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RAF1—lung cancer	0.000109	0.000295	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—lung cancer	0.000109	0.000294	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—lung cancer	0.000108	0.000171	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—HRAS—lung cancer	0.000107	0.000291	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—lung cancer	0.000107	0.000291	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—lung cancer	0.000107	0.000291	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—lung cancer	0.000107	0.00029	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—lung cancer	0.000106	0.000288	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000105	0.000285	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—lung cancer	0.000105	0.000166	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—lung cancer	0.000105	0.000284	CbGpPWpGaD
Acamprosate—Diarrhoea—Doxorubicin—lung cancer	0.000105	0.000166	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—lung cancer	0.000105	0.000283	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TF—lung cancer	0.000104	0.000282	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BRAF—lung cancer	0.000103	0.000278	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000102	0.000277	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—lung cancer	0.000102	0.000277	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB3—lung cancer	0.000101	0.000275	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—lung cancer	0.000101	0.00016	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—BRAF—lung cancer	0.000101	0.000273	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—lung cancer	9.99e-05	0.000271	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—lung cancer	9.78e-05	0.000265	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—lung cancer	9.75e-05	0.000264	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6R—lung cancer	9.73e-05	0.000264	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—lung cancer	9.73e-05	0.000154	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—CREBBP—lung cancer	9.72e-05	0.000264	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—lung cancer	9.71e-05	0.000263	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—lung cancer	9.64e-05	0.000153	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—lung cancer	9.64e-05	0.000153	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MDM2—lung cancer	9.63e-05	0.000261	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—RAF1—lung cancer	9.6e-05	0.00026	CbGpPWpGaD
Acamprosate—Headache—Doxorubicin—lung cancer	9.58e-05	0.000152	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MMP9—lung cancer	9.53e-05	0.000259	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6R—lung cancer	9.49e-05	0.000257	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CREBBP—lung cancer	9.47e-05	0.000257	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR1—lung cancer	9.43e-05	0.000256	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—EP300—lung cancer	9.42e-05	0.000256	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—lung cancer	9.34e-05	0.000253	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—lung cancer	9.29e-05	0.000252	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—lung cancer	9.29e-05	0.000252	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAP2K1—lung cancer	9.27e-05	0.000252	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—lung cancer	9.1e-05	0.000247	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—lung cancer	9.09e-05	0.000144	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MMP2—lung cancer	9.05e-05	0.000246	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAP2K1—lung cancer	9.04e-05	0.000245	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—lung cancer	9.02e-05	0.000245	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—lung cancer	8.96e-05	0.000243	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	8.92e-05	0.000242	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—lung cancer	8.88e-05	0.000241	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BRAF—lung cancer	8.81e-05	0.000239	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SRC—lung cancer	8.79e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—lung cancer	8.78e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—NRAS—lung cancer	8.67e-05	0.000235	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MDM2—lung cancer	8.6e-05	0.000233	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—RAF1—lung cancer	8.57e-05	0.000232	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—lung cancer	8.56e-05	0.000232	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—NRAS—lung cancer	8.46e-05	0.000229	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MDM2—lung cancer	8.44e-05	0.000229	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—RAF1—lung cancer	8.42e-05	0.000228	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AVP—lung cancer	8.41e-05	0.000228	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—lung cancer	8.31e-05	0.000225	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AVP—lung cancer	8.26e-05	0.000224	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RAF1—lung cancer	8.22e-05	0.000223	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—lung cancer	8.2e-05	0.000222	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	8.19e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—lung cancer	8.18e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—lung cancer	8.18e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—lung cancer	8.18e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—lung cancer	8.18e-05	0.000222	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—lung cancer	8.14e-05	0.000221	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—lung cancer	8.14e-05	0.000221	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK3—lung cancer	8.1e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGF—lung cancer	8.09e-05	0.000219	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	8.04e-05	0.000218	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RAF1—lung cancer	8.02e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—lung cancer	8.01e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—lung cancer	8e-05	0.000217	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—lung cancer	7.93e-05	0.000215	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—lung cancer	7.9e-05	0.000214	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—lung cancer	7.84e-05	0.000213	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—lung cancer	7.79e-05	0.000211	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—lung cancer	7.7e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BRAF—lung cancer	7.69e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6R—lung cancer	7.6e-05	0.000206	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CREBBP—lung cancer	7.59e-05	0.000206	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—lung cancer	7.47e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—lung cancer	7.45e-05	0.000202	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MDM2—lung cancer	7.38e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—RAF1—lung cancer	7.36e-05	0.0002	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—lung cancer	7.28e-05	0.000197	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAP2K1—lung cancer	7.24e-05	0.000196	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	7.22e-05	0.000196	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—lung cancer	7.19e-05	0.000195	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—lung cancer	7.15e-05	0.000194	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—lung cancer	7.12e-05	0.000193	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—lung cancer	7.07e-05	0.000192	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—lung cancer	7.04e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	7.03e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	6.99e-05	0.00019	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—lung cancer	6.98e-05	0.000189	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—lung cancer	6.97e-05	0.000189	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—lung cancer	6.8e-05	0.000185	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EP300—lung cancer	6.62e-05	0.000179	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—lung cancer	6.47e-05	0.000175	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EP300—lung cancer	6.45e-05	0.000175	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MDM2—lung cancer	6.44e-05	0.000175	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—lung cancer	6.43e-05	0.000175	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—lung cancer	6.43e-05	0.000174	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RAF1—lung cancer	6.42e-05	0.000174	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—lung cancer	6.35e-05	0.000172	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—lung cancer	6.35e-05	0.000172	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	6.31e-05	0.000171	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—lung cancer	6.27e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—lung cancer	6.27e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—lung cancer	6.27e-05	0.00017	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—lung cancer	6.27e-05	0.00017	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—lung cancer	6.21e-05	0.000168	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—lung cancer	6.19e-05	0.000168	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—lung cancer	6.19e-05	0.000168	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	6.17e-05	0.000167	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	6.16e-05	0.000167	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—lung cancer	6.11e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—lung cancer	6.07e-05	0.000165	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—lung cancer	6.05e-05	0.000164	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	6.05e-05	0.000164	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRAS—lung cancer	6.03e-05	0.000164	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—lung cancer	6.02e-05	0.000163	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—lung cancer	5.99e-05	0.000162	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—lung cancer	5.93e-05	0.000161	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—lung cancer	5.92e-05	0.000161	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—lung cancer	5.82e-05	0.000158	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—lung cancer	5.78e-05	0.000157	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—lung cancer	5.77e-05	0.000156	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—lung cancer	5.76e-05	0.000156	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—lung cancer	5.73e-05	0.000155	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—lung cancer	5.64e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—lung cancer	5.61e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—lung cancer	5.6e-05	0.000152	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	5.52e-05	0.00015	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—lung cancer	5.5e-05	0.000149	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—lung cancer	5.45e-05	0.000148	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	5.44e-05	0.000148	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—lung cancer	5.43e-05	0.000147	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—lung cancer	5.42e-05	0.000147	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.34e-05	0.000145	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—lung cancer	5.33e-05	0.000145	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	5.29e-05	0.000143	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—lung cancer	5.29e-05	0.000143	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—lung cancer	5.19e-05	0.000141	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EP300—lung cancer	5.17e-05	0.00014	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	5.09e-05	0.000138	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—lung cancer	5.02e-05	0.000136	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	5e-05	0.000136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—lung cancer	4.89e-05	0.000133	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—lung cancer	4.85e-05	0.000131	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—lung cancer	4.83e-05	0.000131	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—lung cancer	4.72e-05	0.000128	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.67e-05	0.000127	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—lung cancer	4.63e-05	0.000126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—lung cancer	4.63e-05	0.000126	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	4.61e-05	0.000125	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—lung cancer	4.53e-05	0.000123	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	4.52e-05	0.000123	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—lung cancer	4.5e-05	0.000122	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—lung cancer	4.41e-05	0.00012	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—lung cancer	4.4e-05	0.000119	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	4.37e-05	0.000119	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—lung cancer	4.33e-05	0.000118	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—lung cancer	4.23e-05	0.000115	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—lung cancer	4.16e-05	0.000113	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—lung cancer	4.05e-05	0.00011	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—lung cancer	4e-05	0.000108	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	3.95e-05	0.000107	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—lung cancer	3.9e-05	0.000106	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—lung cancer	3.82e-05	0.000104	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—lung cancer	3.7e-05	0.0001	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—lung cancer	3.54e-05	9.59e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—lung cancer	3.38e-05	9.18e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—lung cancer	3.12e-05	8.47e-05	CbGpPWpGaD
